The Pediatric Hematology/Oncology division of Emory University is the only Pediatric Cancer Center within a radius of 180 miles. This center offers multimodal therapy to children with malignant diseases. The division cares for children in the Atlanta area (population - 2 million), the state of Georgia, and other neighboring states including Alabama, and North and South Carolina. Emory University is the largest contributor of patients to the Pediatric Oncology Group (POG) and has been so for the last 7 years, earlier in SWOG. Approximately 10% of all POG patients enrolled in studies emanate from Emory University. Again, Emory University is the largest single contributor of patients to POG Phase I and II studies. Several basic research projects are currently underway at Emory University. These include the investigation of granulopoiesis in children with acute non-lymphocytic leukemia (ANLL). Bone Marrow cells from all children with ANLL are sent to Emory University. These are cultured in agar and methylcellulose, and the various growth patterns are correlated with prognosis. The prognostic implication of the differentiation of ANLL cells in culture (as measured by monoclonal antibodies and NBT reduction) is also being investigated. Bone marrow cells are incubated in liquid culture with retinoic acid, cytosine arabinoside and homoharringonine and the degree of differentiation to mature myeloid cells is measured by monoclonal antibody fluorescence and NBT reduction. This differentiation may have prognostic and therapeutic implications. We are also attempting to develop cell lines from children with acute leukemia. To date, we have been successful in establishing a cell line from a child with Pre-B cell line. Studies are also underway with Dr. Andrew Chen (Genetics) at Center for Disease Control to evaluate the incidence and significance of chromosomal breaks in the bone marrow cells of children with acute leukemia. In addition, we are attempting to culture and develop cell lines from children with Brain tumors. We are also in the process of developing 3 monoclonal antibodies to TE-671, the medulloblastoma cell line. These studies may help in the treatment of children with malignant disorders.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA020549-13
Application #
3556538
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1978-01-01
Project End
1990-12-31
Budget Start
1989-01-01
Budget End
1989-12-31
Support Year
13
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Wacker, Pierre; Land, Vita J; Camitta, Bruce M et al. (2007) Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. J Pediatr Hematol Oncol 29:627-32
Ravindranath, Y; Chang, M; Steuber, C P et al. (2005) Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 19:2101-16
Adamkiewicz, T V; Mehta, P S; Boyer, M W et al. (2004) Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant 34:405-11
Seitzman, Robin L; Glover, Dorie A; Meadows, Anna T et al. (2004) Self-concept in adult survivors of childhood acute lymphoblastic leukemia: a cooperative Children's Cancer Group and National Institutes of Health study. Pediatr Blood Cancer 42:230-40
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Goorin, Allen M; Schwartzentruber, Douglas J; Devidas, Meenakshi et al. (2003) Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21:1574-80
Laver, Joseph H; Mahmoud, Hazem; Pick, Terry E et al. (2002) Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study. Leuk Lymphoma 43:105-9
Bell, B A; Chang, M N; Weinstein, H J (2001) A phase II study of Homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: a pediatric oncology group study. Med Pediatr Oncol 37:103-7
Lauer, S J; Shuster, J J; Mahoney Jr, D H et al. (2001) A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial. Leukemia 15:1038-45
Saylors 3rd, R L; Stine, K C; Sullivan, J et al. (2001) Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. J Clin Oncol 19:3463-9

Showing the most recent 10 out of 67 publications